Canada markets open in 1 hour 27 minutes

Emerald Health Therapeutics, Inc. (EMHTF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.2027+0.0001 (+0.05%)
At close: 3:55PM EDT

Emerald Health Therapeutics, Inc.

800 West Pender Street
Suite 210
Vancouver, BC V6C 1J8
800 757 3536

IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees161

Key Executives

NameTitlePayExercisedYear Born
Dr. Avtar S. DhillonExec. Chairman387.44kN/A1962
Mr. Riaz Bandali M.B.A.CEO & Pres342.04kN/A1970
Ms. Jenn Hepburn B.B.A.CFO & Company Sec.761.08kN/AN/A
Mr. Orville BovenschenSr. VP of OperationsN/AN/AN/A
Mr. Bernie HertelVP of Fin. and CommunicationsN/AN/AN/A
Ms. Rebecca WongSr. VP of Quality & Regulatory AffairsN/AN/AN/A
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Emerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada.

Corporate Governance

Emerald Health Therapeutics, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.